The Effect of Vagus Nerve Stimulation on Cycling Ergometry and Recovery
TAVNSCER
he Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Cycling Ergometry and Recovery in Healthy Young Individuals
1 other identifier
interventional
90
1 country
1
Brief Summary
It is aIt is aimed to examine the possible benefits and effects of the use of Transcutaneous Auricular Vagus Nerve Stimulation to be applied in healthy individuals for sportive purposes on recovery and sportive performance level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2021
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedFirst Posted
Study publicly available on registry
March 21, 2023
CompletedMarch 21, 2023
March 1, 2023
3 months
September 15, 2021
March 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Evaluation of autonomous parameters
Systolic / diastolic blood pressure (mmHg) will be measured with the Braun sphygmomanometer.
In the 4-day protocol, it was measured 12 times in total, before and after vagus therapy with the bicycle ergometer test.
Numerical Fatigue Rating Scale
The fatigue NRS is a patient-administered, single-item, 11-point horizontal scale anchored at 0 and 10, with 0 representing 'no fatigue' and 10 representing 'as bad as you can imagine'. Patients are asked to 'please rate your fatigue (weariness, tiredness) by selecting the number.
In the 4-day protocol, it was measured 12 times in total, before and after vagus therapy with the bicycle ergometer test.
Numerical Pain Rating Scale
Pain intensity is frequently measured on an 11-point pain intensity numerical rating scale (PI-NRS), where 0=no pain and 10=worst possible pain.
In the 4-day protocol, it was measured 12 times in total, before and after vagus therapy with the bicycle ergometer test.
Bicycle Ergometer Test
All participants will be asked to perform cycling exercise at maximum performance for 30 minutes under a load of 30 watts. Then, the distance (meters) covered during the exercise will be evaluated for the sportive performance of the participants.
It was measured 4 times in aggregation in the 4-day protocol.
Lactat Scout
For lactic acid analysis measurement, the middle fingertip of the athlete is disinfected with an alcohol swab and a blood sample is taken by puncturing the finger.The measuring range is 0.5 - 0.25 mmol/L.
It was measured 4 times in total on the 1st and 2nd days of the 4-day protocol.
Polar H10
RR times transferred to computer with Polar H10 are used in heart rate variability analysis. Heart rate data will be transferred to the Kubios program and heart rate variability parameters will be calculated and data on the autonomic nervous system (RMSSD, PNS index, Stress index, SNS index, pNN50, Power LF, Power HF and LF/HF ratio) will be obtained.
It was measured 4 times in total on the 1st and 2nd days of the 4-day protocol.
Study Arms (3)
Unilateral Stimulation
EXPERIMENTALAfter evaluating with 7 different parameters on the first, second, third and fourth days of the protocol, the participants in all groups will be asked to do cycling exercise with maximum performance for 30 minutes under the same wattage load. It will be re-evaluated after the cycling exercise application. After the assessment is complete, stimulation will be given with Vagustim non-invasively for 30 minutes. After vagus nerve stimulation, a re-evaluation will be made and the protocol for that day will be terminated. With the Vagustim device, vagus nerve stimulation will be applied in one ear for 20 minutes, with a frequency of 10 Hz, a pulse width of 300 μs in Modulation mode, and a constant current that the participant will feel the current comfortably.
Bilateral Stimulation
EXPERIMENTALAfter evaluating with 7 different parameters on the first, second, third and fourth days of the protocol, the participants in all groups will be asked to do cycling exercise with maximum performance for 30 minutes under the same wattage load. It will be re-evaluated after the cycling exercise application. After the assessment is complete, stimulation will be given with Vagustim non-invasively for 20minutes. After vagus nerve stimulation, a re-evaluation will be made and the protocol for that day will be terminated. With the Vagustim device, vagus nerve stimulation will be applied in bilateral ear for 20 minutes, with a frequency of 10 Hz, a pulse width of 300 μs in Modulation mode, and a constant current that the participant will feel the current comfortably.
Bilateral Sham Stimulation
SHAM COMPARATORAfter evaluating with 7 different parameters on the first, second, third and fourth days of the protocol, the participants in all groups will be asked to do cycling exercise with maximum performance for 30 minutes under the same wattage load. Bisiklet egzersiz uygulaması sonrasında tekrar değerlendirilecektir. It will be re-evaluated after the cycling exercise. After the assessment is complete, sham stimulation with Vagustim for 20 minutes will be given non-invasively. After vagus nerve stimulation, a re-evaluation will be made and the protocol for that day will be terminated.
Interventions
With the Vagustim device, vagus nerve stimulation will be applied in one ear for 20 minutes, with a frequency of 10 Hz, a pulse width of 300 μs in Modulation mode, and a constant current that the participant will feel the current comfortably.
With the Vagustim device, vagus nerve stimulation will be applied in one ear for 20 minutes, with a frequency of 10 Hz, a pulse width of 300 μs in Modulation mode, and a constant current that the participant will feel the current comfortably.
Participants were shown that the device was working, but no current was given.
Participants in this group were asked to perform bicycle exercise with maximum performance under 30 watts for 30 minutes.
For lactic acid analysis measurement, the middle fingertip of the athlete is disinfected with an alcohol swab and a blood sample is taken by puncturing the finger.The measuring range is 0.5 - 0.25 mmol/L.
RR times transferred to computer with Polar H10 are used in heart rate variability analysis. Heart rate data will be transferred to the Kubios program and heart rate variability parameters will be calculated and data on the autonomic nervous system (RMSSD, PNS index, Stress index, SNS index, pNN50, Power LF, Power HF and LF/HF ratio) will be obtained.
Vagustim Health Technologies Vagus stimulator device is used for this experiment.
Eligibility Criteria
You may qualify if:
- Healthy individuals between the ages of 18-35,
- Willingness to participate in the study
- Having signed the informed consent form
You may not qualify if:
- Cases do not want to continue the study.
- Having regular sports habits or starting in the working process,
- Having a disease related to the respiratory system and starting to use drugs
- Having a disease related to the cardiac system and starting to use drugs
- Presence of any chronic disease and using a drug related to it
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sinop Universitylead
Study Sites (1)
Sefa Haktan Hatik
Sinop, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
SEFA HAKTAN HATIK, Asst. Prof
Sinop University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2021
First Posted
March 21, 2023
Study Start
March 1, 2022
Primary Completion
June 1, 2022
Study Completion
August 1, 2022
Last Updated
March 21, 2023
Record last verified: 2023-03